Hanmi Pharm Co Ltd
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company's products include Gugutams, a urological combination therapy combining two activ… Read more
Hanmi Pharm Co Ltd (128940) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.031x
Based on the latest financial reports, Hanmi Pharm Co Ltd (128940) has a cash flow conversion efficiency ratio of 0.031x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩42.02 Billion) by net assets (₩1.35 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hanmi Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Hanmi Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hanmi Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hanmi Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Corporación Inmobiliaria Vesta S.A.B. de C.V
PINK:VESTF
|
0.025x |
|
Sunrise Communications AG
NASDAQ:SNRE
|
0.071x |
|
DELIVEROO PLC
F:926
|
N/A |
|
Nuvei Corp
NASDAQ:NVEI
|
0.030x |
|
Valeo SA
PA:FR
|
0.246x |
|
UNO Minda Limited
NSE:UNOMINDA
|
0.040x |
|
NORTHERN OIL A.GAS DL-001
F:4LT1
|
N/A |
|
BaoViet Holdings
VN:BVH
|
-0.311x |
Annual Cash Flow Conversion Efficiency for Hanmi Pharm Co Ltd (2010–2024)
The table below shows the annual cash flow conversion efficiency of Hanmi Pharm Co Ltd from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.24 Trillion | ₩193.49 Billion | 0.156x | -20.77% |
| 2023-12-31 | ₩1.10 Trillion | ₩216.54 Billion | 0.197x | +22.41% |
| 2022-12-31 | ₩1.01 Trillion | ₩162.27 Billion | 0.161x | -26.09% |
| 2021-12-31 | ₩928.26 Billion | ₩201.92 Billion | 0.218x | +19.42% |
| 2020-12-31 | ₩831.89 Billion | ₩151.53 Billion | 0.182x | +1103.39% |
| 2019-12-31 | ₩822.26 Billion | ₩12.45 Billion | 0.015x | -54.02% |
| 2018-12-31 | ₩789.26 Billion | ₩25.98 Billion | 0.033x | +141.47% |
| 2017-12-31 | ₩792.42 Billion | ₩-62.91 Billion | -0.079x | -114.12% |
| 2016-12-31 | ₩734.52 Billion | ₩412.97 Billion | 0.562x | +311.70% |
| 2015-12-31 | ₩744.81 Billion | ₩101.71 Billion | 0.137x | +345.18% |
| 2014-12-31 | ₩589.25 Billion | ₩-32.82 Billion | -0.056x | -129.98% |
| 2013-12-31 | ₩462.92 Billion | ₩85.99 Billion | 0.186x | +20.19% |
| 2012-12-31 | ₩409.34 Billion | ₩63.27 Billion | 0.155x | -4.64% |
| 2011-12-31 | ₩378.22 Billion | ₩61.30 Billion | 0.162x | +178.39% |
| 2010-12-31 | ₩325.38 Billion | ₩18.94 Billion | 0.058x | -- |